XOMA Ltd. | TalkMarkets

Latest Posts

An Activist Fund Has Been Buying This Biotech

Article By: Scott Matusow

Friday, January 17, 2020 11:00 AM EDT

When a fund files a 13D, it indicates that it intends to be an activist investor. Activist investors often facilitate new business paths, partnerships, and acquisitions.

In this article: FPRX Also: BMY, MRK, ZLAB, XOMA

Read

5 Biotech Stocks Set For Continued Rally In 2020

Article By: Zacks Investment Research

Monday, December 16, 2019 4:00 PM EDT

With the advance in RNA interference and gene therapy and given the positive developments throughout 2019, the space has high scope of growth in 2020.

In this article: XOMA, CHRS, MRNA, QURE, MGTX

Read

Hedge Funds Have Never Been Less Bullish On Hi-Crush Inc.

Article By: Insider Monkey

Saturday, November 30, 2019 6:42 PM EDT

Hi-Crush Inc. shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in three hedge funds’ portfolios at the end of the third quarter of 2019.

In this article: HCR Also: OVBC, SPY, XOMA, MNSB, SAMG

Read

Matinas Biopharma Is Highly Undervalued

Article By: Terry Chrisomalis

Monday, September 9, 2019 7:13 AM EDT

With cash concerns put to rest, a solid lead product MAT9001, and a unique lipid nano-crystal delivery technology, I believe Matinas Biopharma is highly undervalued.

In this article: MTNB Also: LGND, XOMA, AMRN, ABUS

Read